These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
654 related articles for article (PubMed ID: 24952258)
1. Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: prognostic value and prospective role in ovarian cancer therapeutics. Koutsaki M; Spandidos DA; Zaravinos A Cancer Lett; 2014 Sep; 351(2):173-81. PubMed ID: 24952258 [TBL] [Abstract][Full Text] [Related]
2. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2. Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366 [TBL] [Abstract][Full Text] [Related]
3. Role of microRNAs in ovarian cancer pathogenesis and potential clinical implications. Mezzanzanica D; Bagnoli M; De Cecco L; Valeri B; Canevari S Int J Biochem Cell Biol; 2010 Aug; 42(8):1262-72. PubMed ID: 20035894 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells. Chen J; Wang L; Matyunina LV; Hill CG; McDonald JF Gynecol Oncol; 2011 Apr; 121(1):200-5. PubMed ID: 21277012 [TBL] [Abstract][Full Text] [Related]
5. Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma. Yoshino H; Enokida H; Itesako T; Tatarano S; Kinoshita T; Fuse M; Kojima S; Nakagawa M; Seki N J Hum Genet; 2013 Aug; 58(8):508-16. PubMed ID: 23635949 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-429 functions as a regulator of epithelial-mesenchymal transition by targeting Pcdh8 during murine embryo implantation. Li Z; Gou J; Jia J; Zhao X Hum Reprod; 2015 Mar; 30(3):507-18. PubMed ID: 25609238 [TBL] [Abstract][Full Text] [Related]
7. Sequence diverse miRNAs converge to induce mesenchymal-to-epithelial transition in ovarian cancer cells through direct and indirect regulatory controls. Zhang M; Jabbari N; Satpathy M; Matyunina LV; Wang Y; McDonald LD; McDonald JF Cancer Lett; 2019 Sep; 459():168-175. PubMed ID: 31163194 [TBL] [Abstract][Full Text] [Related]
8. MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells. Dong P; Xiong Y; Watari H; Hanley SJ; Konno Y; Ihira K; Yamada T; Kudo M; Yue J; Sakuragi N J Exp Clin Cancer Res; 2016 Sep; 35(1):132. PubMed ID: 27596137 [TBL] [Abstract][Full Text] [Related]
9. miRNA-200a/c as potential biomarker in epithelial ovarian cancer (EOC): evidence based on miRNA meta-signature and clinical investigations. Teng Y; Su X; Zhang X; Zhang Y; Li C; Niu W; Liu C; Qu K Oncotarget; 2016 Dec; 7(49):81621-81633. PubMed ID: 27835595 [TBL] [Abstract][Full Text] [Related]
10. miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer. Tan H; He Q; Gong G; Wang Y; Li J; Wang J; Zhu D; Wu X Int J Oncol; 2016 Jan; 48(1):181-90. PubMed ID: 26575700 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer. Aydoğdu E; Katchy A; Tsouko E; Lin CY; Haldosén LA; Helguero L; Williams C Carcinogenesis; 2012 Aug; 33(8):1502-11. PubMed ID: 22562546 [TBL] [Abstract][Full Text] [Related]
12. Ectopic over-expression of miR-429 induces mesenchymal-to-epithelial transition (MET) and increased drug sensitivity in metastasizing ovarian cancer cells. Wang L; Mezencev R; Švajdler M; Benigno BB; McDonald JF Gynecol Oncol; 2014 Jul; 134(1):96-103. PubMed ID: 24802724 [TBL] [Abstract][Full Text] [Related]
13. The Functions of MicroRNA-200 Family in Ovarian Cancer: Beyond Epithelial-Mesenchymal Transition. Choi PW; Ng SW Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587302 [TBL] [Abstract][Full Text] [Related]
14. Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker. Vilming Elgaaen B; Olstad OK; Haug KB; Brusletto B; Sandvik L; Staff AC; Gautvik KM; Davidson B BMC Cancer; 2014 Feb; 14():80. PubMed ID: 24512620 [TBL] [Abstract][Full Text] [Related]
15. The miR-200 family differentially regulates sensitivity to paclitaxel and carboplatin in human ovarian carcinoma OVCAR-3 and MES-OV cells. Brozovic A; Duran GE; Wang YC; Francisco EB; Sikic BI Mol Oncol; 2015 Oct; 9(8):1678-93. PubMed ID: 26025631 [TBL] [Abstract][Full Text] [Related]
16. The microRNA-200 family: still much to discover. Senfter D; Madlener S; Krupitza G; Mader RM Biomol Concepts; 2016 Dec; 7(5-6):311-319. PubMed ID: 27837593 [TBL] [Abstract][Full Text] [Related]
17. MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1. Sun L; Yao Y; Liu B; Lin Z; Lin L; Yang M; Zhang W; Chen W; Pan C; Liu Q; Song E; Li J Oncogene; 2012 Jan; 31(4):432-45. PubMed ID: 21725369 [TBL] [Abstract][Full Text] [Related]
18. Inhibitions of epithelial to mesenchymal transition and cancer stem cells-like properties are involved in miR-148a-mediated anti-metastasis of hepatocellular carcinoma. Yan H; Dong X; Zhong X; Ye J; Zhou Y; Yang X; Shen J; Zhang J Mol Carcinog; 2014 Dec; 53(12):960-9. PubMed ID: 23861222 [TBL] [Abstract][Full Text] [Related]
19. Tamoxifen represses miR-200 microRNAs and promotes epithelial-to-mesenchymal transition by up-regulating c-Myc in endometrial carcinoma cell lines. Bai JX; Yan B; Zhao ZN; Xiao X; Qin WW; Zhang R; Jia LT; Meng YL; Jin BQ; Fan DM; Wang T; Yang AG Endocrinology; 2013 Feb; 154(2):635-45. PubMed ID: 23295740 [TBL] [Abstract][Full Text] [Related]